Increased yield of high purity recombinant human interferon-γ utilizing reversed phase column chromatography

Protein Expression and Purification

Volumn 52, Issue 1, 2007, Pages 123-130

  Reddy, Praveen K ^a   Reddy, Srinivasa G ^a   Narala, Venkata R ^a   Majee, Sangita S ^b   Konda, Sudhakar ^b   Gunwar, Sripad ^b   Reddy, Raju C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Virchow Research Institute   (India)

Author keywords

Antiviral assay; Protein expression; Protein purification; Recombinant human interferon ; Reversed phase chromatography

Indexed keywords

GAMMA INTERFERON; PRIMER DNA; RECOMBINANT GAMMA INTERFERON;

ARTICLE; BLOOD; CHEMISTRY; CHROMATOGRAPHY; CULTURE MEDIUM; GEL CHROMATOGRAPHY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR CLONING; RESTRICTION MAPPING; SOLUBILITY;

CHROMATOGRAPHY; CHROMATOGRAPHY, GEL; CLONING, MOLECULAR; CULTURE MEDIA; DNA PRIMERS; HUMANS; INTERFERON TYPE II; INTERFERON-GAMMA, RECOMBINANT; RESTRICTION MAPPING; SOLUBILITY;

ESCHERICHIA COLI;

EID: 33845917534     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.08.013     Document Type: Article

References (44)

1. Trinchieri G., and Perussia B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol. Today 6 (1985) 131-136
2. Stewart II W.E. The Interferon System (1979), Springer, Verlag, Berlin
3. Langer J.A., and Pestka S. Structure of interferons. Pharmacol. Ther. 27 (1985) 371-401
4. Pestka S., Langer J.A., Zoon K.C., and Samuel C.E. Interferons and their actions. Annu. Rev. Biochem. 56 (1987) 727-777
5. Salazar-Mather T.P., and Hokeness K.L. Cytokine and chemokine networks: pathways to antiviral defense. Curr. Top. Microbiol. Immunol. 303 (2006) 29-46
6. Ezekowitz R.A., Dinauer M.C., Jaffe H.S., Orkin S.H., and Newburger P.E. Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N. Engl. J. Med. 319 (1988) 146-151
7. Sechler J.M., Malech H.L., White C.J., and Gallin J.I. Recombinant human interferon-γ reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc. Natl. Acad. Sci. USA 85 (1988) 4874-4878
8. Nunoi H., Ishibashi F., Mizukami T., and Hidaka F. Clinical evaluation of interferon-γ treatment to chronic granulomatous disease patients with splice site mutations. Jpn. J. Infect. Dis. 57 (2004) S25-S26
9. Marciano B.E., Wesley R., De Carlo E.S., Anderson V.L., Barnhart L.A., Darnell D., Malech H.L., Gallin J.I., and Holland S.M. Long-term interferon-γ therapy for patients with chronic granulomatous disease. Clin. Infect. Dis. 39 (2004) 692-699
10. Key Jr. L.L., Rodriguiz R.M., Willi S.M., Wright N.M., Hatcher H.C., Eyre D.R., Cure J.K., Griffin P.P., and Ries W.L. Long-term treatment of osteopetrosis with recombinant human interferon gamma. N. Engl. J. Med. 332 (1995) 1594-1599
11. Kocher M.S., and Kasser J.R. Osteopetrosis. Am. J. Orthop. 32 (2003) 222-228
12. Bajwa E.K., Ayas N.T., Schulzer M., Mak E., Ryu J.H., and Malhotra A. Interferon-γ 1b therapy in idiopathic pulmonary fibrosis, A metaanalysis. Chest. 128 (2005) 203-206
13. Suarez-Mendez R., Garcia-Garcia I., Fernandez-Olivera N., Valdes-Quintana M., Milanes-Virelles M.T., Carbonell D., Machado-Molina D., Valenzuela-Silva C.M., and Lopez-Saura P.A. Adjuvant interferon gamma in patients with drug-resistant pulmonary tuberculosis: a pilot study. BMC Infect. Dis. 4 (2004) 44
14. Chang T.T., and Stevens S.R. Atopic dermatitis: the role of recombinant interferon-γ therapy. Am. J. Clin. Dermatol. 3 (2002) 175-183
15. Parvez M.K., Sehgal D., Sarin S.K., Basir S.F., and Jameel S. Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-γ. World J. Gastroenterol. 12 (2006) 3006-3014
16. Yashiro K., Lowenthal J.W., O'Neil T.E., Ebisu S., Takagi H., and Moore R.J. High-level production of recombinant chicken interferon-γ by Brevibacillus choshinensis. Protein Expr. Purif. 23 (2001) 113-120
17. Xia C., Dan W., Wen-Xue W., Jian-Qing W., Li W., Tian-Yao Y., Qin W., and Yi-Bao N. Cloning and expression of interferon-alpha/gamma from a domestic porcine breed and its effect on classical swine fever virus. Vet. Immunol. Immunopathol. 104 (2005) 81-89
18. Zhang Z., Tong K.T., Belew M., Pettersson T., and Janson J.C. Production, purification and characterization of recombinant human interferon gamma. J. Chromatogr. 604 (1992) 143-155
19. Khalilzadeh R., Shojaosadati S.A., Bahrami A., and Maghsoudi N. Over-expression of recombinant human interferon-gamma in high cell density fermentation of Escherichia coli. Biotechnol. Lett. 25 (2003) 1989-1992
20. Khalilzadeh R., Shojaosadati S.A., Maghsoudi N., Mohammadian-Mosaabadi J., Mohammadi M.R., Bahrami A., Maleksabet N., Nassiri-Khalilli M.A., Ebrahimi M., and Naderimanesh H. Process development for production of recombinant human interferon-gamma expressed in Escherichia coli. J. Ind. Microbiol. Biotechnol. 31 (2004) 63-69
21. Mohammadian-Mosaabadi J., Naderi-Manesh H., Maghsoudi N., Khalilzadeh R., Shojaosadati S.A., and Ebrahimi M. Effect of oxidative stress on the production of recombinant human interferon-gamma in Escherichia coli. Biotechnol. Appl. Biochem. 41 (2005) 37-42
22. Mannall G.J., Titchener-Hooker N.J., Chase H.A., and Dalby P.A. A critical assessment of the impact of mixing on dilution refolding. Biotechnol. Bioeng. 93 (2006) 955-963
23. Singh S.M., and Panda A.K. Solubilization and refolding of bacterial inclusion body proteins. J. Biosci. Bioeng. 99 (2005) 303-310
24. Jin T., Guan Y.X., Yao S.J., Lin D.Q., and Cho M.G. On-column refolding of recombinant human interferon-gamma inclusion bodies by expanded bed adsorption chromatography. Biotechnol. Bioeng. 93 (2006) 755-760
25. Vandenbroeck K., Martens E., D'Andrea S., and Billiau A. Refolding and single-step purification of porcine interferon-gamma from Escherichia coli inclusion bodies, Conditions for reconstitution of dimeric IFN-gamma. Eur. J. Biochem. 215 (1993) 481-486
26. Yphantis D.A., and Arakawa T. Sedimentation equilibrium measurements of recombinant DNA derived human interferon gamma. Biochemistry. 26 (1987) 5422-5427
27. L.N. Marekov, R.A. Vassileva, V.P. Ivanov, A.A. Sarafova, R.G. Zanev, I.G. Ivanov, V.S. Ivanova, Method for producing of recombinant human cysteine less gamma-interferon free of methionine at N-terminal, Eur. Patent App. No. 0446582 AI.
28. Perez L., Vega J., Chuay C., Menendez A., Ubieta R., Montero M., Padron G., Silva A., Santizo C., Besada V., and Herrera L. Production and characterization of human gamma interferon from Escherichia coli. Appl. Microbiol. Biotechnol. 33 (1990) 429-434
29. Arora D., and Khanna N. Method for increasing the yield of properly folded recombinant human gamma interferon from inclusion bodies. J. Biotechnol. 52 (1996) 127-133
30. Haelewyn J., and De Ley M. A rapid single-step purification method for human interferon-gamma from isolated Escherichia coli inclusion bodies. Biochem. Mol. Biol. Int. 37 (1995) 1163-1171
31. Honda S., Asano T., Kajio T., Nakagawa S., Ikeyama S., Ichimori Y., Sugino H., Nara K., Kakinuma A., and Kung H.F. Differential purification by immunoaffinity chromatography of two carboxy-terminal portion-deleted derivatives of recombinant human interferon-gamma from Escherichia coli. J. Interferon Res. 7 (1987) 145-154
32. Arnau J., Lauritzen C., Petersen G.E., and Pedersen J. Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins. Protein Expr. Purif. 48 (2006) 1-13
33. Lu H., Zhang H., Wang Q., Yuan H., He W., Zhao Z., and Li Y. Purification, refolding of hybrid hIFNgamma-kringle 5 expressed in Escherichia coli. Curr. Microbiol. 42 (2001) 211-216
34. Ejima D., Yumioka R., Arakawa T., and Tsumoto K. Arginine as an effective additive in gel permeation chromatography. J. Chromatogr. A. 1094 (2005) 49-55
35. Cho T.H., Ahn S.J., and Lee E.K. Refolding of protein inclusion bodies directly from Escherichia coli homogenate using expanded bed adsorption chromatography. Bioseparation 10 (2002) 189-196
36. Geng X., Bai Q., Zhang Y., Li X., and Wu D. Refolding and purification of interferon-gamma in industry by hydrophobic interaction chromatography. J. Biotechnol. 113 (2004) 137-149
37. Wang F., Liu Y., Li J., Ma G., and Su Z. On-column refolding of consensus interferon at high concentration with guanidine-hydrochloride and polyethylene glycol gradients. J. Chromatogr. A. 1115 (2006) 72-80
38. Gao Y.G., Guan Y.X., Yao S.J., and Cho M.G. On-column refolding of recombinant human interferon-gamma with an immobilized chaperone fragment. Biotechnol. Prog. 19 (2003) 915-920
39. Guan Y.X., Fei Z.Z., Luo M., Yao S.J., and Cho M.G. Production of minichaperone (sht GroEL191-345) and its function in the refolding of recombinant human interferon gamma. Protein Pept. Lett. 12 (2005) 85-88
40. Guan Y.X., Fei Z.Z., Luo M., Jin T., and Yao S.J. Chromatographic refolding of recombinant human interferon gamma by an immobilized sht GroEL191-345 column. J. Chromatogr. A. 1107 (2006) 192-197
41. Pechenov S.E., Tikhonov R.V., Shingarova L.N., Korobko V.G., Yakimov S.A., Klyushnichenko V.E., Babajantz A.A., Beliaev D.L., Kuznetzov V.P., Shvetz V.I., and Wulfson A.N. Methods for preparation of recombinant cytokine proteins, V, mutant analogues of human interferon-gamma with higher stability and activity. Protein Expr. Purif. 24 (2002) 173-180
42. Jacobson A. Purification and fractionation of poly(A)+ RNA. Methods Enzymol. 152 (1987) 254-261
43. Lewis J.A. Antiviral activity of cytokines. In: Richwood D., and Homes B.D. (Eds). Cytokines. (1988), Oxford University Press, New York 129-141
44. Gray P.W., Leung D.W., Pennica D., Yelverton E., Najarian R., Simonsen C.C., Derynck R., Sherwood P.J., Wallace D.M., Berger S.L., Levinson A.D., and Goeddel D.V. Expression of human immune interferon cDNA in Escherichia coli and monkey cells. Nature. 295 (1982) 503-508